{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:33Z","timestamp":1792511913152,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11239-019-01826-9","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T03:30:15Z","timestamp":1550115015000},"page":"540-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-9286","authenticated-orcid":false,"given":"Tomasz","family":"Nowakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof Piotr","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Ni\u017cankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iwaniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"Suppl 1","key":"1826_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 33(Suppl 1):S1\u2013S75","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5603\/KP.a2017.0016","volume":"75","author":"P Wierzchowski","year":"2017","unstructured":"Wierzchowski P, Derezi\u0144ski T, Migdalski A, Woda \u0141, W\u0105sikowska B, Jakubowski G et al (2017) Cross-sectional study of the ankle\u2013 brachial index and cardiovascular risk factors in postmenopausal women. Kardiol Pol 75:486\u2013494. \n                    https:\/\/doi.org\/10.5603\/KP.a2017.0016","journal-title":"Kardiol Pol"},{"key":"1826_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"F Fowkes","year":"2013","unstructured":"Fowkes F, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM et al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329\u20131340","journal-title":"Lancet"},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2016.04.071","volume":"68","author":"MH Shishehbor","year":"2016","unstructured":"Shishehbor MH, White CJ, Gray BH, Menard MT, Lookstein R, Rosenfield K et al (2016) Critical limb ischemia. An expert statement. J Am Coll Cardiol 68:2002\u20132015","journal-title":"J Am Coll Cardiol"},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","volume":"51","author":"VN Varu","year":"2010","unstructured":"Varu VN, Hogg ME, Kibbe MR (2010) Critical limb ischemia. J Vasc Surg 51:230\u2013241","journal-title":"J Vasc Surg"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"e001946","DOI":"10.1161\/CIRCINTERVENTIONS.115.001946","volume":"9","author":"S Kinlay","year":"2016","unstructured":"Kinlay S (2016) Management of critical limb ischemia. Circ Cardiovasc Interv 9:e001946","journal-title":"Circ Cardiovasc Interv"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehx095","volume":"00","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco JB, Bartelink ML, Bj\u00f6rck M, Brodmann M, Cohnert T et al (2017) ESC guidelines on the diagnosis and treatment of peripheral artery diseases, in collaboration with the European society for vascular surgery. Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The task force on the diagnosis and treatment of peripheral artery diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J 00:1\u201360. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx095","journal-title":"Eur Heart J"},{"key":"1826_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ahj.2013.12.012","volume":"167","author":"WS Jones","year":"2014","unstructured":"Jones WS, Dolor RJ, Hasselblad V, Vemulapalli S, Subherwal S, Schmit K et al (2014) Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am Heart J 167:489\u2013498","journal-title":"Am Heart J"},{"key":"1826_CR9","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.jcin.2016.09.039","volume":"24","author":"T Bisdas","year":"2016","unstructured":"Bisdas T, Borowski M, Stavroulakis K, Torsello G, for the CRITISCH Collaborators (2016) Endovascular therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia results of the interim analysis of the CRITISCH registry. J Am Coll Cardiol 24:2557\u20132565. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2016.09.039","journal-title":"J Am Coll Cardiol"},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jcin.2013.08.007","volume":"12","author":"M Fusaro","year":"2013","unstructured":"Fusaro M, Cassese S, Ndrepepa G, Tepe G, King L, Ott I et al (2013) Drug-eluting stents for revascularization of infrapopliteal arteries: an updated meta-analysis of randomized trials. J Am Coll Cardiol 12:1284\u20131293","journal-title":"J Am Coll Cardiol"},{"key":"1826_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1583\/08-2440.1","volume":"15","author":"M Montero-Baker","year":"2008","unstructured":"Montero-Baker M, Schmidt A, Br\u00e4unlich S, Ulrich M, Thieme M, Biamino G et al (2008) Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther 15:594\u2013604","journal-title":"J Endovasc Ther"},{"key":"1826_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/aje\/kwj051","volume":"63","author":"I Tzoulaki","year":"2006","unstructured":"Tzoulaki I, Murray GD, Price JF, Smith FB, Lee AJ, Rumley A et al (2006) Hemostatic factors, inflammatory markers and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 63:334\u2013341","journal-title":"Am J Epidemiol"},{"issue":"12 Suppl 1","key":"1826_CR13","first-page":"169","volume":"39","author":"EB Smith","year":"1994","unstructured":"Smith EB (1994) Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque. Cardiologia 39(12 Suppl 1):169\u2013172","journal-title":"Cardiologia"},{"key":"1826_CR14","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1161\/01.ATV.0000136649.83297.bf","volume":"24","author":"EM Scott","year":"2004","unstructured":"Scott EM, Ari\u00ebns RA, Grant PJ (2004) Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 24:1558\u20131566","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1826_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/ATVBAHA.111.230631","volume":"31","author":"A Undas","year":"2011","unstructured":"Undas A, Ari\u00ebns RA (2011) Fibrin clot structure and function a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 31:88\u201399","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1160\/TH14-01-0032","volume":"112","author":"A Undas","year":"2014","unstructured":"Undas A (2014) Fibrin clot properties and their modulation in thrombotic disorders. Thromb Haemost 112:32\u201342","journal-title":"Thromb Haemost"},{"key":"1826_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jvs.2008.11.028","volume":"49","author":"N Bhasin","year":"2009","unstructured":"Bhasin N, Parry DJ, Scott DJ, Ari\u00ebns RA, Grant PJ, West RM (2009) Regarding Altered fibrin clot structure and function in individuals with intermittent claudication. J Vasc Surg 49:1088\u20131089","journal-title":"J Vasc Surg"},{"key":"1826_CR18","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jvs.2008.07.010","volume":"48","author":"N Bhasin","year":"2008","unstructured":"Bhasin N, Ari\u00ebns RA, West RM, Parry DJ, Grant PJ, Scott DJ (2008) Altered fibrin clot architecture and function in the healthy first-degree relatives of subjects with intermittent claudication. J Vasc Surg 48:1497\u20131503","journal-title":"J Vasc Surg"},{"key":"1826_CR19","first-page":"608","volume":"122","author":"A Okraska-Bylica","year":"2012","unstructured":"Okraska-Bylica A, Wilkosz T, S\u0142owik L, Bazanek M, Konieczy\u0144ska M, Undas A (2012) Altered fibrin clot properties in patients with premature peripheral artery disease. Pol Arch Med Wewn 122:608\u2013615","journal-title":"Pol Arch Med Wewn"},{"key":"1826_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.atherosclerosis.2010.12.040","volume":"215","author":"A Undas","year":"2011","unstructured":"Undas A, Nowakowski T, Ciesla-Dul M, Sadowski J (2011) Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis 215:481\u2013486","journal-title":"Atherosclerosis"},{"key":"1826_CR21","first-page":"835","volume":"80","author":"J Beregi","year":"1999","unstructured":"Beregi J, Martin-Teule C, Trogrlic S, Meunier J, Crochet D (1999) Quantitative angiography: state of the art for peripheral vascular applications. J Radiol 80:835\u2013841","journal-title":"J Radiol"},{"key":"1826_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000071636","volume":"33","author":"HC Hemker","year":"2003","unstructured":"Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R et al (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4\u201315","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","volume":"114","author":"A Undas","year":"2009","unstructured":"Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopyd\u0142owska A, Skubiszak A, Ciep\u0142uch K et al (2009) Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and their relatives. Blood 114:4272\u20134278","journal-title":"Blood"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/gast.2001.25481","volume":"121","author":"T Lisman","year":"2001","unstructured":"Lisman T, Leebeek FWG, Mosnier LO, Bouma BN, Meijers JC, Janssen HL et al (2001) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 121:131\u2013139","journal-title":"Gastroenterology"},{"key":"1826_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/ATVBAHA.109.194936","volume":"30","author":"A Undas","year":"2010","unstructured":"Undas A, Zalewski J, Krochin M, Siudak Z, Sadowski M, Pr\u0119gowski J et al (2010) Altered plasma fibrin clot properties are associated with in-stent thrombosis. Arterioscler Thromb Vasc Biol 30:276\u2013282","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1826_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0167-4838(89)90140-4","volume":"997","author":"B Blomb\u00e4ck","year":"1989","unstructured":"Blomb\u00e4ck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N (1989) Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 997:96 \u2013 110","journal-title":"Biochim Biophys Acta"},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1160\/TH11-09-0662","volume":"107","author":"O Pankiw-Bembenek","year":"2012","unstructured":"Pankiw-Bembenek O, Zalewski J, Goralczyk T, Undas A (2012) A history of early stent thrombosis is associated with prolonged clot lysis time. Thromb Haemost 107:513\u2013520","journal-title":"Thromb Haemost"},{"key":"1826_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","volume":"115","author":"TF L\u00fcscher","year":"2007","unstructured":"L\u00fcscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051\u20131058","journal-title":"Circulation"},{"key":"1826_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.atherosclerosis.2014.10.020","volume":"237","author":"M Sadowski","year":"2014","unstructured":"Sadowski M, Z\u0105bczyk M, Undas A (2014) Coronary thrombus composition: links with inflammation, platelet and endothelial markers. Atherosclerosis 237:555\u2013561","journal-title":"Atherosclerosis"},{"key":"1826_CR30","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","volume":"117","author":"AO Spiel","year":"2008","unstructured":"Spiel AO, Gilbert JC, Jilma B (2008) Von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 117:1449\u20131459","journal-title":"Circulation"},{"key":"1826_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9150(98)00175-0","volume":"142","author":"DA Tsakiris","year":"1999","unstructured":"Tsakiris DA, Tsch\u00f6pl M, J\u00e4ger K, Haefeli W, Wolf F, Marbet G (1999) Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 142:193\u2013200","journal-title":"Atherosclerosis"},{"key":"1826_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.5604\/17322693.1164409","volume":"69","author":"D Kotschy","year":"2015","unstructured":"Kotschy D, Kotschy M, Socha P, Mas\u0142owski L, Kwapisz J, \u017buk N at al (2015) Selected endothelial hemostatic markers in patients with peripheral arterial disease after endovascular revascularization and restenosis formation. Postepy Hig Med Dosw 69:905\u2013912","journal-title":"Postepy Hig Med Dosw"},{"key":"1826_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","volume":"38","author":"AS Wolberg","year":"2008","unstructured":"Wolberg AS, Campbell RA (2008) Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 38:15\u201323","journal-title":"Transfus Apher Sci"},{"key":"1826_CR34","doi-asserted-by":"publisher","first-page":"e003553","DOI":"10.1161\/JAHA.116003553","volume":"8","author":"H Cate ten","year":"2016","unstructured":"ten Cate H, Hemker HC (2016) Thrombin generation and atherothrombosis: what does the evidence indicate? J Am Heart Assoc 8:e003553. \n                    https:\/\/doi.org\/10.1161\/JAHA.116003553","journal-title":"J Am Heart Assoc"},{"key":"1826_CR35","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1053\/euhj.1998.1088","volume":"19","author":"S Williams","year":"1998","unstructured":"Williams S, Fatah K, Hjemdahl P, Blomb\u00e4ck M (1998) Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J 19:1666 \u2013 1672","journal-title":"Eur Heart J"},{"key":"1826_CR36","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1538-7836.2006.01882.x","volume":"4","author":"A Undas","year":"2006","unstructured":"Undas A, Celinska-L\u00f6wenhoff M, L\u00f6wenhoff T, Szczeklik A (2006) Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. Thromb Haemost 4:1029\u20131036","journal-title":"Thromb Haemost"},{"key":"1826_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/ATVBAHA.116.308253","volume":"37","author":"M Zabczyk","year":"2017","unstructured":"Zabczyk M, Plens K, Wojtowicz W, Undas A (2017) Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism after discontinuation of anticoagulant therapy. Arterioscler Thromb Vasc Biol 37:365\u2013373. DOI:101161\/ATVBAHA. 116.308253","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1826_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1182\/blood-2017-07-798306","volume":"131","author":"J Cieslik","year":"2018","unstructured":"Cieslik J, Mrozinska S, Broniatowska E, Undas A (2018) Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study. Blood 131:797\u2013807. \n                    https:\/\/doi.org\/10.1182\/blood-2017-07-798306","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01826-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:12:30Z","timestamp":1581621150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01826-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01826-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"14 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Jagiellonian University Ethics Committee, and patients provided written informed consent. The study was conducted according to the ICH-GCP guidelines and relevant local and international regulations including but not limited to the 1964 Declaration of Helsinki (WMA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}